Analysts Set Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) PT at $36.60
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) has been given an average rating of “Buy” by the six research firms that are presently covering the company, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12-month target price among brokers that have updated their coverage on the […]
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) has been given an average rating of “Buy” by the six research firms that are presently covering the company, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12-month target price among brokers that have updated their coverage on the […]
